ProCE Banner Activity

Optimal Treatment for Patients With Progressive RCC After 1 or More Previous Lines of Therapy

Slideset Download
Download these slides from a live webinar for the most recent data on the selection and sequencing of therapy for patients with advanced RCC after progression on first-line therapy.

Released: March 01, 2022

Expiration: February 28, 2023

Share

Faculty

Elizabeth Plimack

Elizabeth Plimack, MD, MS

Assistant Professor
Associate Member
Medical Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

Provided by

Provided by National Comprehensive Cancer Network, in partnership with Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Exelixis, Inc.

Merck Sharp & Dohme Corp.

Pfizer, Inc.

Faculty Disclosure

Primary Author

Elizabeth Plimack, MD, MS

Assistant Professor
Associate Member
Medical Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania